Castle biosciences to present new data highlighting the clinical performance of decisiondx®-melanoma and mypath® melanoma at the american society of dermatopathology 61st annual meeting

Friendswood, texas--(business wire)---- $cstl #asdp24--castle will share new data highlighting the clinical performance of its decisiondx-melanoma and mypath melanoma tests at the asdp 61st annual meeting.

CSTL Ratings Summary

CSTL Quant Ranking